|
1GZK
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation
Deposited 2002-05-23
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
146–460(315 aa)
Fragment:KINASE DOMAIN, RESIDUES (146 - 460)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10MG/ML PROTEIN, 30% PEG4K, 0.2 M LITHIUM SULPHATE, 0.1 M TRIS, pH 7.50
|
Resolution 2.30 Å
R-free 0.319
|
|
1GZN
Structure of PKB kinase domain
Deposited 2002-05-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
146–480(335 aa)
Fragment:KINASE DOMAIN AND HYDROPHOBIC MOTIF, RESIDUES 146-480
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;30% PEG 8K, 0.2 M LITHIUM SULPHATE 0.1 M TRIS, 10 MG/ML PROTEIN, pH 7.50
|
Resolution 2.50 Å
R-free 0.319
|
|
1GZO
Structure of protein kinase B unphosphorylated
Deposited 2002-05-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
146–460(315 aa)
Fragment:KINASE DOMAIN WITHOUT HYDROPHOBIC MOTIF, RESIDUES 146-460
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;30% PEG 8000, 0.2 M LITHIUM SULPHATE, 0.1 M TRIS, 10MG/ML PROTEIN, pH 7.50
|
Resolution 2.75 Å
R-free 0.310
|
|
1MRV
crystal structure of an inactive Akt2 kinase domain
Deposited 2002-09-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
143–481(339 aa)
Fragment:kinase domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;Li2SO4, PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.295
|
|
1MRY
crystal structure of an inactive akt2 kinase domain
Deposited 2002-09-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
143–481(339 aa)
Fragment:kinase domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;Li2SO4, PEG 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.272
|
|
1O6K
Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP
Deposited 2002-10-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–481(336 aa)
Fragment:KINASE DOMAIN, RESIDUES 146-481
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MN MANGANESE (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10 MG/ML PROTEIN 20 PEG 4K, 10% ISOPROPONAL, 5 MM DTT, pH 7.50
|
Resolution 1.70 Å
R-free 0.234
|
|
1O6L
Crystal structure of an activated Akt/protein kinase B (PKB-PIF chimera) ternary complex with AMP-PNP and GSK3 peptide
Deposited 2002-10-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–467(322 aa)
Fragment:KINASE DOMAIN, RESIDUES 146 - 467
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MN MANGANESE (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10 MG/ML PROTEIN, 20% (W/V) POLYETHYLENE, GLYCOL 4000, 10% (V/V) ISOPROPANOL, 0.1 M HEPES (PH 7.5), 5 MM DTT
|
Resolution 1.60 Å
R-free 0.227
|
|
1P6S
Solution Structure of the Pleckstrin Homology Domain of Human Protein Kinase B beta (Pkb/Akt)
Deposited 2003-04-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–111(111 aa)
Fragment:Pleckstrin Homology Domain (residues 1-111)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;286 K;Ionic strength (raw mmCIF value) 0.3;Pressure ambient
NMR measurement conditions
pH 7.4;286 K;Ionic strength (raw mmCIF value) 0.3;Pressure ambient
NMR sample composition
0.4mM PKBbeta-PH U-15N,13C; 10mM Tris-HCl; 300mM NaCl; 0.1mM Benzamidine; 0.1mM EDTA; 4mM Inositol-1,4,5-trisphosphate; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4mM PKBbeta-PH U-15N; 10mM Tris-HCl; 300mM NaCl; 0.1mM Benzamidine; 0.1mM EDTA; 4mM Inositol-1,4,5-trisphosphate; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2JDO
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE
Deposited 2007-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–467(322 aa)
Fragment:KINASE CATALYTIC DOMAIN, RESIDUES 146-467
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
I5S ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
R-free 0.210
|
|
2JDR
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
Deposited 2007-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–467(322 aa)
Fragment:KINASE CATALYTIC DOMAIN, RESIDUES 146-467
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
L20 (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.30 Å
R-free 0.252
|
|
2UW9
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-chloro-phenyl)-4-(4-(1H-pyrazol-4-yl)-phenyl)-piperidine
Deposited 2007-03-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–467(322 aa)
Fragment:KINASE CATALYTIC DOMAIN, RESIDUES 146-467
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GVP 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
R-free 0.305
|
|
2X39
Structure of 4-Amino-N-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin- 4-yl)piperidine-4-carboxamide bound to PKB
Deposited 2010-01-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–467(322 aa)
Fragment:KINASE CATALYTIC DOMAIN, RESIDUES 146-467
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
X39 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.93 Å
R-free 0.226
|
|
2XH5
Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB
Deposited 2010-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–479(334 aa)
Fragment:KINASE CATALYTIC DOMAIN, RESIDUES 146-467
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
X37 4-(4-tert-butylbenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.72 Å
R-free 0.305
|
|
3E87
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–480(335 aa)
Fragment:Akt2 kinase domain (146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G95 N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.30 Å
R-free 0.246
|
|
3E87
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
146–480(335 aa)
Fragment:Akt2 kinase domain (146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G95 N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.30 Å
R-free 0.246
|
|
3E88
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–480(335 aa)
Fragment:Akt2 kinase domain (146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G96 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.50 Å
R-free 0.273
|
|
3E88
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
146–480(335 aa)
Fragment:Akt2 kinase domain (146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G96 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.50 Å
R-free 0.273
|
|
3E8D
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
146–480(335 aa)
Fragment:Akt2 kinase domain (UNP residues 146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G98 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.70 Å
R-free 0.268
|
|
3E8D
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
Deposited 2008-08-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
146–480(335 aa)
Fragment:Akt2 kinase domain (UNP residues 146-480)
|
Mutation:S474D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
G98 4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;298 K;14% PEG 2KMME, 100 mM Tris pH 8.0 and 10% ethanol diffused in. Seeded., vapor diffusion, temperature 298K
|
Resolution 2.70 Å
R-free 0.268
|
|
8Q61
Co-crystal structure of human AKT2 with compound 3
Deposited 2023-08-10
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–481(481 aa)
|
Mutation:N2D
|
K06 6-[4-(1-azanyl-3-methyl-3-oxidanyl-cyclobutyl)phenyl]-7-phenyl-1-propyl-pyrido[2,3-b][1,4]oxazin-2-one × 1
GOL GLYCEROL × 1
PO4 PHOSPHATE ION × 3
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1 M MES, 1.5 M NaH2PO4
|
Resolution 2.32 Å
R-free 0.263
|
|
9C1W
Structure of AKT2 with compound 3
Deposited 2024-05-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–447(446 aa)
|
Mutation:P115A, G116A
|
XOO 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde × 1
EDO 1,2-ETHANEDIOL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M HEPES pH 7.5, 20 % w/v PEG 8000
|
Resolution 2.00 Å
R-free 0.242
|